OncoInv, a Netherlands-based company focused on multi-cancer early detection, has signed a distribution agreement with MaxBloch Clinical Laboratories to introduce OncoSeek(R) , its multi-cancer early ...
The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...
Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated ...
When NASA scientists opened the sample return canister from the OSIRIS-REx asteroid sample mission in late 2023, they found ...
Morning Overview on MSN
AI found cancer patterns that shocked the researchers
Artificial intelligence is no longer just spotting tumors a little faster than humans. In study after study, machine learning ...
The National Institute for Research and Treatment (NICRAT) has trained health workers in Nigeria’s Southwest geopolitical ...
Cancer-diagnosing AI models can secretly read patient demographics from pathology slides, leading to biased results.
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 44th Annual J.P. Morgan ...
AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that Providence Swedish Cancer Institute and the ...
Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude ...
Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback